Better than a needle in the eye: New medical device offers hope and relief for patients

February 2, 2012
New medical device offers hope and relief for patients
A close-up photo of the microneedles found on the surface of a new McMaster-developed device that can deliver drugs to the back of the eye. The device could offer more effective treatment while sparing patients the excruciating routine of having drugs injected directly into their eyes via syringe every six to eight weeks.

(Medical Xpress) -- Researchers at McMaster have developed a new system for delivering drugs to the back of the eye - one that could offer more effective treatment while sparing patients with vision-related diseases the excruciating routine of having drugs injected into their eyes by syringe every six to eight weeks.

Instead, the new system could deliver medicine painlessly to the back of the eye through a flexible patch that would typically stay on the eye behind the lens for as much as a year at a time, slowly releasing controlled doses of medicine to the vitreous body of the eye through a group of "microneedles" too small to feel.

The rubbery patch is designed to conform to the eye's contour and the needles can be tailored to reach specific layers of the eye as needed. The patch would be attached on an in-patient basis and would not affect the patient's when in use.

The team of chemical and mechanical engineers tested the system successfully on eyes extracted from , moving the concept a major step closer to being tested on humans. The innovation is described in an article in the online edition of the Journal of Biomaterials Applications.

The patch can be compared to medication patches used on the skin, but on a much smaller scale and using different materials adapted to the complex environment of the eye.

Such a patch would be a much more precise and effective vehicle for delivering medications to patients with such conditions as vision-related complications of diabetes and age-related , both of which are becoming more prevalent.

"There's lots of potential for treating eye diseases that we didn't have even five years ago. It's really exciting," said the study's co-author, Heather Sheardown, a professor of chemical engineering. "There are medications out there to treat these diseases. As we develop better delivery methods, isn't going to be something that has to happen. If we can catch the disease early and we can treat it early, we can stop its progression."

Sheardown's lab, which focuses on delivering drugs to the back of the eye, will turn next to developing a reservoir system to allow drugs in such patches to be replenished externally.

The technical challenge for the team that developed the patch device was not only to find a way to deliver drugs in such a challenging setting, but to use affordable materials so the system can compete with hypodermic , explained co-author Ravi Selvaganapathy, an associate professor of mechanical engineering.

"All these stringent requirements were daunting. But the design solution that emerged was elegant," he said.

The researchers received funding from the Natural Sciences and Engineering Research Council of Canada.

Explore further: Startup receives $4 million to develop drug delivery targeted to the back of the eye

Related Stories

Startup receives $4 million to develop drug delivery targeted to the back of the eye

January 5, 2012
Technology developed by researchers at the Georgia Institute of Technology and Emory University for delivering drugs and other therapeutics to specific locations in the eye provides the foundation for a startup company that ...

Smart contact lenses could make eye drops a thing of the past

November 9, 2011
(Medical Xpress) -- An Auburn University team of chemical and biomedical engineers led by Mark Byrne, the Daniel F. and Josephine Breeden Associate Professor in the Samuel Ginn College of Engineering, has developed a new ...

Whether we know it or not, we can 'see' through one eye at a time

October 17, 2011
Although portions of the visible world come in through one eye only, the brain instantaneously takes all that information and creates a coherent image. As far as we know, we 'see' with both eyes at once. Now a new study suggests ...

Recommended for you

Scientists regenerate retinal cells in mice

July 26, 2017
Scientists have successfully regenerated cells in the retina of adult mice at the University of Washington School of Medicine in Seattle.

Genome editing with CRISPR-Cas9 prevents angiogenesis of the retina

July 24, 2017
A research team from the Schepens Eye Research Institute of Massachusetts Eye and Ear has successfully prevented mice from developing angiogenesis of the retina—the sensory tissue at the back of the eye—using gene-editing ...

Too little vitamin D may hinder recovery of injured corneas

July 24, 2017
Injury or disease in combination with too little vitamin D can be bad for the window to your eyes.

Combination of type 2 diabetes and sleep apnoea indicates eyesight loss within four years

July 4, 2017
Research led by the University of Birmingham has discovered that patients who suffer from both Type 2 diabetes and obstructive sleep apnoea are at greater risk of developing a condition that leads to blindness within an average ...

Nearly 60% of pinkeye patients receive antibiotic eye drops, but they're seldom necessary

June 28, 2017
A new study suggests that most people with acute conjunctivitis, or pinkeye, are getting the wrong treatment.

Magnetic implants used to treat 'dancing eyes'

June 26, 2017
A research team has successfully used magnets implanted behind a person's eyes to treat nystagmus, a condition characterised by involuntary eye movements.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.